2019 Mercantile Law, Q9

X Pharmaceuticals, Inc. has been manufacturing the antibiotic ointment Marvelopis, which is covered by a patent expiring in the year 2020. In January 2019, the company filed an application for a new patent for Disilopis, which, although constituting the same substance as Marvelopis, is no longer treated as an antibiotic but is targeted and marketed for a new use, i.e., skin whitening.
(a) What are the three (3) requisites of patentability under the Intellectual Property Code? (3%)
(b) Should X Pharmaceuticals, Inc.’s patent application for Disilopis be granted? Explain. (2%)

Quick check

Under Section 21 of the Intellectual Property Code, what are the three essential requisites for an invention to be patentable?

Under Republic Act Number 9502 (Cheaper Medicines Act), what is the rule regarding the discovery of a new use for a known drug substance?

What practice does Section 22 of the Intellectual Property Code seek to prevent by excluding new uses of known substances from patentability?

Why should X Pharmaceuticals, Inc.'s patent application for Disilopis be denied by the Intellectual Property Office?

Choices available with full access.

Which statute amended the Intellectual Property Code to restrict patentability of new uses for known pharmaceutical substances in the Philippines?

Choices available with full access.

Unlock the full Commercial Law answers

Learn more about these topics

1. Patentability Requisites
Under Section 21 of the Intellectual Property Code of the Philippines (Republic Act Number 8293), any technical solution of a problem in any field of human activity which is new, involves an inventive step, and is industrially applicable is patentable. Novelty requires that an invention does not form part of the prior art. An inventive step exists if, having regard to the prior art, the invention is not obvious to a person skilled in the art. Industrial applicability requires that the invention can be produced or used in any industry.

2. Non-Patentable Discoveries
Under Section 22.1 of Republic Act Number 8293, as amended by the Cheaper Medicines Act (Republic Act Number 9502), the mere discovery of a new form or new property of a known substance which does not result in the enhancement of the known efficacy of that substance, or the mere discovery of any new use for a known substance, is non-patentable. This statutory prohibition prevents pharmaceutical companies from engaging in evergreening, a practice where patent monopolies are artificially extended by applying for new patents over known active chemical substances based solely on newly discovered medical uses.

3. Pharmaceutical Evergreening Prohibition
Evergreening refers to the practice of obtaining multiple patents over a single pharmaceutical compound by filing subsequent applications for minor modifications, new formulations, or new therapeutic uses. Under Republic Act Number 9502, Philippine patent law strictly excludes new uses of existing active drug substances from patent protection to ensure public access to affordable generic medicines. Consequently, when a pharmaceutical entity attempts to patent a known active substance merely by rebranding or marketing it for a different therapeutic application, the patent application must be denied for lack of novelty and inventive step.

About these questions and answers
The questions reproduced here are the official texts of the Philippine Bar Examinations, published by the Supreme Court. They are reproduced for study purposes.The suggested answers are the author’s own.

They are not official answers, have no connection with the Supreme Court, the Office of the Bar Confidant, or any bar review institution, and are not endorsed by any of them. Official answer keys, where released, should be preferred over anything here.Nothing on this page is legal advice, and reading it creates no lawyer-client relationship. Do not rely on any suggested answer in an actual legal matter. Consult counsel on your own facts.Suggested answers reflect the law and jurisprudence the author considers applicable as of the date shown.

Where a question comes from an earlier examination, the suggested answer applies the law as it now stands, which may differ from the law in force when the question was given, and may therefore differ from what would have been the correct answer at that time. Where the difference is material, the answer notes it.The practice scoring feature measures wording overlap with the suggested answer. It is not a grade, carries no official weight, and says nothing about whether your reasoning is sound.Errors are possible. If you find one, please tell me and I will correct it.Last reviewed: October 2026